Einar Gudlaugsson

2.6k total citations
89 papers, 1.8k citations indexed

About

Einar Gudlaugsson is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Einar Gudlaugsson has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 33 papers in Cancer Research and 25 papers in Surgery. Recurrent topics in Einar Gudlaugsson's work include Breast Cancer Treatment Studies (24 papers), Cervical Cancer and HPV Research (16 papers) and Endometrial and Cervical Cancer Treatments (14 papers). Einar Gudlaugsson is often cited by papers focused on Breast Cancer Treatment Studies (24 papers), Cervical Cancer and HPV Research (16 papers) and Endometrial and Cervical Cancer Treatments (14 papers). Einar Gudlaugsson collaborates with scholars based in Norway, Netherlands and United States. Einar Gudlaugsson's co-authors include Ivar Skaland, Jan P. A. Baak, Emiel A. M. Janssen, Emiel A. M. Janssen, Håvard Søiland, Jon Arne Søreide, Anaís Malpica, Kjetil Søreide, Jan Kłos and Jan P. A. Baak and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Einar Gudlaugsson

87 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Einar Gudlaugsson Norway 25 699 599 469 447 382 89 1.8k
Reda S. Saad United States 27 753 1.1× 344 0.6× 533 1.1× 509 1.1× 381 1.0× 66 2.0k
Kristen A. Atkins United States 24 574 0.8× 465 0.8× 412 0.9× 353 0.8× 303 0.8× 71 1.8k
Carmen Gomez‐Fernandez United States 25 1.1k 1.6× 547 0.9× 478 1.0× 627 1.4× 240 0.6× 88 2.3k
Ivar Skaland Norway 23 467 0.7× 565 0.9× 528 1.1× 238 0.5× 337 0.9× 66 1.5k
Cristina Riva Italy 28 821 1.2× 606 1.0× 575 1.2× 468 1.0× 614 1.6× 69 2.3k
Mamatha Chivukula United States 23 532 0.8× 543 0.9× 347 0.7× 292 0.7× 192 0.5× 53 1.7k
Ahwon Lee South Korea 24 415 0.6× 440 0.7× 500 1.1× 319 0.7× 194 0.5× 140 1.8k
Roberto Dina United Kingdom 29 619 0.9× 510 0.9× 871 1.9× 490 1.1× 596 1.6× 81 2.6k
Franco Fulciniti Italy 22 444 0.6× 308 0.5× 383 0.8× 519 1.2× 270 0.7× 108 1.6k
Moritz Jesinghaus Germany 25 1.1k 1.6× 351 0.6× 395 0.8× 492 1.1× 526 1.4× 92 2.0k

Countries citing papers authored by Einar Gudlaugsson

Since Specialization
Citations

This map shows the geographic impact of Einar Gudlaugsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einar Gudlaugsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einar Gudlaugsson more than expected).

Fields of papers citing papers by Einar Gudlaugsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Einar Gudlaugsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einar Gudlaugsson. The network helps show where Einar Gudlaugsson may publish in the future.

Co-authorship network of co-authors of Einar Gudlaugsson

This figure shows the co-authorship network connecting the top 25 collaborators of Einar Gudlaugsson. A scholar is included among the top collaborators of Einar Gudlaugsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Einar Gudlaugsson. Einar Gudlaugsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gambacorta, Marcello, Einar Gudlaugsson, Svein Reidar Kjosavik, et al.. (2025). Artificial intelligence-assisted prostate cancer diagnosis for reduced use of immunohistochemistry. Communications Medicine. 5(1). 425–425.
2.
Gudlaugsson, Einar, et al.. (2023). Automated Prognostic Assessment of Endometrial Hyperplasia for Progression Risk Evaluation Using Artificial Intelligence. Modern Pathology. 36(5). 100116–100116. 4 indexed citations
3.
Gudlaugsson, Einar, et al.. (2020). Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer. PLoS ONE. 15(6). e0233676–e0233676. 5 indexed citations
4.
Jónsdóttir, Kristín, Ivar Skaland, Cathrine F. Hjorth, et al.. (2020). <p>Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients</p>. Clinical Epidemiology. Volume 12. 771–781. 4 indexed citations
5.
Austdal, Marie, Einar Gudlaugsson, Jan P. A. Baak, et al.. (2019). Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients. PLoS ONE. 14(3). e0212527–e0212527. 8 indexed citations
6.
Lende, Tone Hoel, Marie Austdal, Ivar Skaland, et al.. (2019). Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial. BMC Cancer. 19(1). 1076–1076. 15 indexed citations
7.
8.
9.
Feng, Weiwei, Keqin Hua, Einar Gudlaugsson, et al.. (2013). Prognostic indicators in WHO 2003 low‐grade endometrial stromal sarcoma. Histopathology. 62(5). 675–687. 23 indexed citations
10.
Søndenaa, Karl, Kristian Eeg Storli, Sabine Leh, et al.. (2013). The total number of lymph nodes in resected colon cancer specimens is affected by several factors but the lymph node ratio is independent of these. Apmis. 122(6). 490–498. 9 indexed citations
11.
Feng, Weiwei, Anaís Malpica, Stanley J. Robboy, et al.. (2012). Prognostic Value of the Diagnostic Criteria Distinguishing Endometrial Stromal Sarcoma, Low Grade From Undifferentiated Endometrial Sarcoma, 2 Entities Within the Invasive Endometrial Stromal Neoplasia Family. International Journal of Gynecological Pathology. 32(3). 299–306. 15 indexed citations
12.
Jónsdóttir, Kristín, Hui Zhang, Ivar Skaland, et al.. (2012). The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer. Breast Cancer Research and Treatment. 135(2). 381–390. 19 indexed citations
13.
Øvestad, Irene Tveiterås, Einar Gudlaugsson, Kjell Løvslett, et al.. (2012). Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study. Infectious Agents and Cancer. 7(1). 30–30. 10 indexed citations
14.
Zhang, Hui, Emiel A. M. Janssen, Ivar Skaland, et al.. (2011). The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer.. Anticancer Research. 31(2). 443–9. 14 indexed citations
15.
Malpica, Anaís, Einar Gudlaugsson, Emiel A. M. Janssen, et al.. (2011). High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases. Cellular Oncology. 34(5). 457–465. 12 indexed citations
16.
Gudlaugsson, Einar, Ivar Skaland, Anaís Malpica, et al.. (2011). Molecular biomarkers in endometrial hyperplasias predict cancer progression. American Journal of Obstetrics and Gynecology. 204(4). 357.e1–357.e12. 26 indexed citations
17.
Øvestad, Irene Tveiterås, Einar Gudlaugsson, Ivar Skaland, et al.. (2010). Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression. Modern Pathology. 23(9). 1231–1240. 59 indexed citations
18.
Janssen, Emiel A. M., Einar Gudlaugsson, Kristín Jónsdóttir, et al.. (2010). Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Modern Pathology. 23(12). 1567–1576. 56 indexed citations
19.
20.
Baak, Jan P. A., P. J. van Diest, Emiel A. M. Janssen, et al.. (2007). Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers. Annals of Oncology. 19(4). 649–654. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reda S. Saad Breakdown of academic impact, for papers by Kristen A. Atkins Breakdown of academic impact, for papers by Carmen Gomez‐Fernandez Breakdown of academic impact, for papers by Ivar Skaland Breakdown of academic impact, for papers by Cristina Riva Breakdown of academic impact, for papers by Mamatha Chivukula Breakdown of academic impact, for papers by Ahwon Lee Breakdown of academic impact, for papers by Roberto Dina Breakdown of academic impact, for papers by Franco Fulciniti Breakdown of academic impact, for papers by Moritz Jesinghaus
Rankless by CCL
2026